This is a semi-annual review of Type 1 Diabetes research in human clinical trials. The review identified 361 open trials that focus on T1D and only 11 initiatives have the potential to deliver a Practical Cure.
Over the three years that T1D projects in human trials have been tracked, the story has remained more or less unchanged: there are very few Practical Cure projects. More qualifying projects in human trials would significantly increase the chances of a successful outcome.
In a year, the number of qualifying initiatives has moved from 8 to 11, with the addition of two new projects and one returning. The returning project, ATG/GCSF, recently started Phase II trials, after over two years of inactivity. No project has been removed since November 2014.
The accompanying chart lists the Practical Cure projects in human trials as of June 2015. A more detailed record of the Practical Cure research in human trials can be located at www.clinicaltrials.gov website.